51656-70-3

Basic information

• Product Name: Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]-
• Synonyms: Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]-;(2-tert-butoxy-2-oxoethyl)zinc(II) bromide;bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]-
• CAS NO: 51656-70-3
• Molecular Formula: C₆H₁₁BrO₂Zn
• Molecular Weight: 260.44434
• EINECS: -0
• Mol File: 51656-70-3.mol
• Article Data: 32

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]-(51656-70-3)
• EPA Substance Registry System: Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]-(51656-70-3)

Safety Data

• Hazardous Substances Data: 51656-70-3(Hazardous Substances Data)

Usage

General Description

Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]- is a complex chemical compound that contains both zinc and bromine atoms. The compound is characterized by the presence of a bromo group attached to a carbon atom that is part of a larger molecular structure containing two dimethylethoxy groups. Zinc, bromo[2-(1,1-dimethylethoxy)-2-oxoethyl]- likely has specific chemical properties and potential applications due to the presence of the zinc and bromine atoms along with the unique structural arrangement of the molecule. Further research and analysis would be necessary to fully understand the potential uses and effects of this chemical compound.

Upstream product

• 5292-43-3 bromoacetic acid tert-butyl ester 
• 7440-66-6 zinc 
• 75-77-4 chloro-trimethyl-silane 

Downstream Products

• 540-88-5 acetic acid tert-butyl ester 
• 926-26-1 di-tert-Butyl succinate 
• 92975-35-4 (E)-4-Methyl-hex-2-enedioic acid 6-tert-butyl ester 1-methyl ester 
• 115375-63-8 Cyclohexen-⁽¹⁾-yl-essigsaeure-tert-butylester 
• 33155-59-8 tert-butyl 2-(4-chlorophenyl)acetate 
• 155495-87-7 tert-butyl 3-(4-toluenesulfonamido)-3-phenylpropanoate 
• 119421-07-7 (3-Chloro-phenylsulfinamoyl)-acetic acid tert-butyl ester 
• 119421-05-5 (4-Methoxy-phenylsulfinamoyl)-acetic acid tert-butyl ester 
• 119421-04-4 (4-Dimethylamino-phenylsulfinamoyl)-acetic acid tert-butyl ester 
• 115375-71-8 (4-Methylsulfanyl-phenyl)-acetic acid tert-butyl ester 
• 115375-64-9 (4-tert-Butyl-cyclohex-1-enyl)-acetic acid tert-butyl ester 
• 16537-10-3 tert-butyl 3-phenylpropanoate 
• 140-11-4 Benzyl acetate 
• 103-50-4 dibenzyl ether 

Relevant articles and documents

MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl amides. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS

A series of substituted 4,4-difluorocyclohexyl derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

FUSED IMIDAZOLE DERIVATIVES AS IL-17 MODULATORS

A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C-R1 or N; B represents C-R2 or N; D represents C-R3 or N; E represents C-R4 or N; Z represents -CH(R5)N(H)CH2R6, -CH(R5)N(H)S(O)2R6, -C(=CR5aR5b)N(H)C(O)R6, -CH(R5)R7, -CH(R5)N(H)R7 or -CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl.